drugset
drugset / Trial / NCT05726318

Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women

NCT05726318 ↗

Phase 4 Completed 70 enrolled Megan Bradley National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the feasibility of recruiting eligible subjects into a randomized trial of a culture-directed versus empiric antibiotic strategy for patient-reported urinary tract infection symptoms in older women and the adherence to study procedures.

Timeline

Start
2023-02-17
Primary completion
2024-08-02
Completion
2024-08-02

Drugs

EvaluationDrugModalityDoseRoute
Background CEPHALEXIN ANHYDROUS Small molecule 500 mg Oral
Background Ciprofloxacin Small molecule 250 mg Oral
Background Fosfomycin Small molecule 3 g Oral
Background Nitrofurantoin Unknown 100 mg Oral
Background trimethoprim/sulfamethoxazole Unknown 125 mg Oral
Background trimethoprim/sulfamethoxazole Unknown 875 mg Oral

Indications

urinary tract infection